Aadi Bioscience Valuation

Aadi Bioscience Investor Information

About 50.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aadi Bioscience recorded a loss per share of 2.28. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 27th of August 2021. Based on the measurements of operating efficiency obtained from Aadi Bioscience's historical financial statements, Aadi Bioscience is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.

Aadi Bioscience Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aadi Bioscience has an asset utilization ratio of 18.39 percent. This signifies that the Company is making $0.18 for each dollar of assets. An increasing asset utilization means that Aadi Bioscience is more efficient with each dollar of assets it utilizes for everyday operations.

Aadi Bioscience Ownership Allocation

Aadi Bioscience holds a total of 46.29 Million outstanding shares. Over half of Aadi Bioscience's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Aadi Bioscience Profitability Analysis

The company reported the previous year's revenue of 24.35 M. Net Loss for the year was (65.77 M) with loss before overhead, payroll, taxes, and interest of (27.54 M).

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aadi Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

If you are still planning to invest in Aadi Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aadi Bioscience's history and understand the potential risks before investing.